About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Carboplatin
- Procedure number
- PSUSA/00000559/202201
- Regulatory outcome
- Variation
Documents
Carboplatin : List of nationally authorised medicinal products - PSUSA/00000559/202201
English (EN) (430.69 KB - PDF)
Carboplatin : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000559/202201
English (EN) (101.04 KB - PDF)
български (BG) (106.4 KB - PDF)
español (ES) (101.43 KB - PDF)
čeština (CS) (103.14 KB - PDF)
dansk (DA) (102.36 KB - PDF)
Deutsch (DE) (107.68 KB - PDF)
eesti keel (ET) (96.24 KB - PDF)
ελληνικά (EL) (110.33 KB - PDF)
français (FR) (100.86 KB - PDF)
hrvatski (HR) (101.64 KB - PDF)
íslenska (IS) (102.89 KB - PDF)
italiano (IT) (109.94 KB - PDF)
latviešu valoda (LV) (101.01 KB - PDF)
lietuvių kalba (LT) (99.46 KB - PDF)
magyar (HU) (101.41 KB - PDF)
Malti (MT) (108.63 KB - PDF)
Nederlands (NL) (104.69 KB - PDF)
norsk (NO) (101.32 KB - PDF)
polski (PL) (101.58 KB - PDF)
português (PT) (99.94 KB - PDF)
română (RO) (98.77 KB - PDF)
slovenčina (SK) (103.95 KB - PDF)
slovenščina (SL) (97.86 KB - PDF)
Suomi (FI) (98.32 KB - PDF)
svenska (SV) (100.61 KB - PDF)